Skip to content

Artificial Intelligence for Automated Diagnosis of Breast Cancer

Study of an Artificial Intelligence Algorithm for the Classification of Digital Tomosynthesis Breast Images for Automated Breast Cancer Diagnosis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05858762
Acronym
AICAMAMMELLA
Enrollment
200
Registered
2023-05-15
Start date
2020-10-20
Completion date
2023-12-31
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Diagnosis

Brief summary

Mammography is a two-dimensional imaging technique which involves the tissues overlapping under the projective image; dense glandular tissue above or below the lesion can reduce the visibility of the lesion. The trouble could be the interpretation of the image obtained which may lead to the inability to visualize a fist stage cancer and the probability that to a healthy person will be diagnosed a pathology that is not present (false positive). The introduction of an almost three-dimensional technique imaging called breast digital tomosynthesis (DBT) can overcome most limitations. In the last 5 years image analysis methods based on Artificial Intelligence (, AI) have also been massively introduced in breast cancer detection. The study is a prospective observational study based on Artificial intelligence whose the mail goal is to develop a method to identify a lesion.

Interventions

DIAGNOSTIC_TESTBreast digital tomosynthesis

Introduction of an almost three-dimensional imaging technique called breast digital tomosynthesis

Sponsors

Regina Elena Cancer Institute
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who refer to the Regina Elena for diagnostic mammography tests * Informed consent

Exclusion criteria

* presence of prostheses, artifacts, outcomes of a study in the breast intervention under the study

Design outcomes

Primary

MeasureTime frameDescription
Artificial Intelligence system to detect a lesion12 monthsLesion detction is based on breast density, case type, BIRADS assessment categories, mammographic appearance, size and pathological profile of malignant lesions

Countries

Italy

Contacts

Primary ContactValeria Landoni
valeria.landoni@ifo.it+39 06 52665602

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026